Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberPRODUCT SPECIFIC12-May-2010ID # PDCI-083301-297122. Case # and Name3074 Grotan (*)Chemical # and Name083301Hexahydro-1,3,5-tris(2-hydroxyethyl)-s-triazine5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."N.A.N.A.N.A.N.A.N.A.N.A.N.A.N.A.10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company's Authorized Representative__________________________________INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC12-May-2010PDCI-083301-297122. Case # and Name3074 Grotan (*)EPA Reg. No. 1258-10718. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Product Chemistry Data Requirements (Antimicrobial)(14)830.15508EP, PAI & TGAIM, XProduct Identity and composition(53)830.16008EP; MP; TGAIM, XDescription of materials used to produce the product(3)830.16208TGAIM, XDescription of production process(4)830.16508MP, EPM, XDescription of formulation process(5)830.16708EP; MP; TGAIM, XDiscussion of formation of impurities(6 ,8 ,9)830.17008TGAIM, XPreliminary analysis(7)830.17508EP; MP; TGAIM, XCertified limits(10)830.18008EP; MP; TGAIM, XEnforcement analytical method(12)830.63028EP; MP; TGAIM, XColor(13)830.63038EP; MP; TGAIM, XPhysical state(1)830.63048EP; MP; TGAIM, XOdor12. Name of Company13. Phone NumberSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 2 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC12-May-2010PDCI-083301-297122. Case # and Name3074 Grotan (*)EPA Reg. No. 1258-10718. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(15 ,16 ,54)830.63138TGAIM, XStability to sunlight, normal and elevatedtemperatures, metals, and metal ions(2)830.63148MP, EPM, XOxidizing or reducing action(17)830.63158MP, EPM, XFlammability(18)830.63168MP, EPM, XExplodability(11)830.631716MP, EPM, XStorage stability of product(19)830.63198MP, EPM, XMiscibility(55)830.632016MP, EPM, XCorrosion characteristics(20)830.63218MP, EPM, XDielectric breakdown voltage(21 ,22)830.70008EP; MP; TGAIM, XpH of water solutions or suspensions830.70508TGAI/PAIM, XUV/Visible absorption(23)830.71008MP, EPM, XViscosity(24 ,25)830.72008TGAIM, XMelting point/melting rangeInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 3 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC12-May-2010PDCI-083301-297122. Case # and Name3074 Grotan (*)EPA Reg. No. 1258-10718. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(26 ,27)830.72208TGAIM, XBoiling point/boiling range(28 ,29)830.73008EP; MP; TGAIM, XDensity/relative density(30 ,31)830.73708TGAI/PAIM, XDissociation constant in water(32)830.75508TGAI/PAIM, XPartition coefficient (n-octanol/water), shake flaskmethod(33)830.75708TGAI/PAIM, XPartition coefficient (n-octanol/water), estimation byliquid chromatography(34)830.78408TGAI/PAIM, XWater solubility: Column elution method, shake flaskmethod(35)830.78608TGAI/PAIM, XWater solubility, generator column method(36 ,37)830.79508TGAI/PAIM, XVapor pressureToxicology Data Requirements (Antimicrobial)(38 ,39 ,56)870.11008EP; MP; TGAIM, XAcute Oral Toxicity (do not select)(40 ,41 ,42,57)870.12008EP; MP; TGAIM, XAcute dermal toxicity(43 ,44 ,45,46)870.13008EP; MP; TGAIM, XAcute inhalation toxicityInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 4 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC12-May-2010PDCI-083301-297122. Case # and Name3074 Grotan (*)EPA Reg. No. 1258-10718. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(47 ,48 ,49,50)870.25008EP; MP; TGAIM, XAcute dermal irritation(51 ,52)870.26008EP; MP; TGAIM, XSkin sensitization870.24008EP, PAI & TGAIM, XAcute eye irritationInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateCase # and Name:3074 Grotan (*)DCI Number:PDCI-083301-29712Page 1 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; TGAI = Technical Grade Active Ingredient [TGAI]; EP, PAI & TGAI = End-Use Product, Pure ActiveIngredient, and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient; MP, EP= Manufacturing Use Product, End Use ProductUse Categories Key:M -X -Indoor nonfood useMaterials preservatives1If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).2Required if the product contains an oxidizing or reducing agent3Data must be provided in accordance with 40 CFR Part 158.330.4Data must be provided in accordance with 40 CFR Part 158.335.5Data must be provided in accordance with 40 CFR Part 158.340.6Data must be provided in accordance with 40 CFR Part 158.345.7Data must be provided in accordance with 40 CFR Part 158.350.8Required for TGAIs and products produced by an integrated system.9If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).10Data must be provided in accordance with 40 CFR Part 158.355.11The 16-month deadline for submission of this study applies if you are conducting a new study for submission to the Agency to satisfy this requirement. In such case, you are required to submit aprogress report to the Agency within 3 months following the deadline for submission of the 90-Day response required for thisPDCI. Further information concerning the development of dataappears on page 7 of the Generic and Product Specific Data Call-In Notice. If you intend to submit an existing study that hasnot been submitted previously to the Agency or to cite previouslysubmitted data, the existing study or citation to the previously submitted study must be submitted along with your 90-Day Response to this PDCI. If the Agency determines that such existingdata are not adequate, you will need to develop and submit new data within the stated deadline.12If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).13If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).14Data must be provided in accordance with 40 CFR Part 158.320.Case # and Name:3074 Grotan (*)DCI Number:PDCI-083301-29712Page 2 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; TGAI = Technical Grade Active Ingredient [TGAI]; EP, PAI & TGAI = End-Use Product, Pure ActiveIngredient, and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient; MP, EP= Manufacturing Use Product, End Use Product15If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).16Data on the stability to metals and metal ions is required only if the active ingredient is expected to come in contact with either material during storage.17Required when the product contains combustible liquids.18Required when the product is potentially explosive.19Required if the product is an emulsifiable liquid and is to be diluted with petroleum solvents.20Required if the end-use product is a liquid and is to be used around electrical equipment.21If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).22Required if the product is dispersible with water.23Required if the product is a liquid.24If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).25Required when the TGAI is solid at room temperature.26If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).27Required if the TGAI is liquid at room temperature.28If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).29True density or specific density are required for all test substances. Data on bulk density is required for MPs that are solidat room temperature.Case # and Name:3074 Grotan (*)DCI Number:PDCI-083301-29712Page 3 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; TGAI = Technical Grade Active Ingredient [TGAI]; EP, PAI & TGAI = End-Use Product, Pure ActiveIngredient, and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient; MP, EP= Manufacturing Use Product, End Use Product30If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).31Required when the test substance contains an acid or base functionality (organic or inorganic) or an alcoholic functionality (organic).32Required if the TGAI or PAI is organic and non-polar.33Required if the TGAI or PAI is organic and non-polar.34If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).35If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).36If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).37Not required for salts.38Not required if test material is a gas or highly volatile.39For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the product is intended and labeled to bediluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the labeling.40Not required if test material is a gas or highly volatile.41For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the product is intended and labeled to bediluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the labeling.42Not required if test material is corrosive to skin or has pH < 2 or >11.5; such a product will be classified as Toxicity Category I on the basis of potential dermal toxicity.43For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the product is intended and labeled to bediluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the labeling.44Required when the product consists of, or under conditions of use will result in, an inhalable material (e.g., gas, vapor, aerosol or particulates).Case # and Name:3074 Grotan (*)DCI Number:PDCI-083301-29712Page 4 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; TGAI = Technical Grade Active Ingredient [TGAI]; EP, PAI & TGAI = End-Use Product, Pure ActiveIngredient, and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient; MP, EP= Manufacturing Use Product, End Use Product45The 870 series studies for the MP and EP are intended to provide data on the acute toxicity of the product. Waivers for any orall of these studies may be granted when the applicant candemonstrate that the combination of inert ingredients is not likely to pose any significant human health risks. Where appropriate, the limit dose approach to testing is recommended.46Required when the product consists of, or under conditions of use will result in, an inhalable material (e.g. gas, volatile substances, or aerosol particulate).47Not required if test material is a gas or highly volatile.48For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the product is intended and labeled to bediluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the labeling.49Not required if test material is corrosive to skin or has pH < 2 or > 11.5; such a product will be classified as Toxicity Category I on the basis of potential eye irritation effects.50Required if intended use of the antimicrobial pesticide product will involve purposeful application on human skin or will result in comparable exposure to the product (e.g. uses in swimming poolwater), or if the active ingredient of the product is known or expected to be metabolized differently by the dermal route of exposure than by the oral route, and a metabolite of the active ingredientis the toxic moiety. The EP shall also be tested if any component of the EP may increase dermal absorption of the active ingredient(s) or potentiate toxic or pharmacologic effects.51For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution. If the product is intended and labeled to bediluted for use, the applicant may also wish to conduct certain studies using the highest diluted concentration (i.e. lowest dilution rate) permitted by the labeling.52Required if repeated dermal exposure is likely to occur under conditions of use.53Data must be provided in accordance with 40 CFR Part 158.325.54Data on stability of the MP and TGAI to storage at normal temperatures are required. Data on the stability of the TGAI to hightemperatures are required if the TGAI is expected to be subjectedto temperatures >50 degrees Celsius (122 degrees Fahrenheit) during production or storage.55The 16-month deadline for submission of this study applies if you are conducting a new study for submission to the Agency to satisfy this requirement. In such case, you are required to submit aprogress report to the Agency within 3 months following the deadline for submission of the 90-Day response required for this PDCI. Further information concerning the development of dataappears on page 7 of the Generic and Product Specific Data Call-In Notice. If you intend to submit an existing study that hasnot been submitted previously to the Agency or to cite previouslysubmitted data, the existing study or citation to the previously submitted study must be submitted along with your 90-Day Response to this PDCI. If the Agency determines that such existingdata are not adequate, you will need to develop and submit new data within the stated deadline.56Diluted EP testing is required to support the end product registration if results using the EP meet the criteria for restricted use classification under 40 CFR Part 152.170(b) or special reviewconsideration under 40 CFR Part 154.7(a)(1).57Diluted EP testing is required to support the end product registration if results using the EP meet the criteria for restricted use classification under 40 CFR Part 152.170(b) or special reviewconsideration under 40 CFR Part 154.7(a)(1).United States Environmental ProtectionAgency Washington, D.C. 20460LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICECo. Nr.Company NameAgent ForAddressCity & StateZipCase # and Name:3074,Grotan (*)TROY CHEMICAL COMPANYLIMITEDLEWIS & HARRISON122 C ST NW STE 740WASHINGTONDC20001365BUCKMAN LABORATORIES INC.1256 NORTH MCLEAN BLVDMEMPHISTN381081448INTERNATIONAL SPECIALTYPRODUCTS1361 ALPS RD.WAYNENJ074701529STEPAN COMPANY22 W. FRONTAGE RD.NORTHFIELDIL600931839BASF CORPORATION100 CAMPUS DRIVEFLORHAM PARKNJ0793233753SURETY LABORATORIES INC242 OLD NEW BURNSWICK ROAD, SUITE 100PISCATAWAYNJ0885468868ARCH CHEMICALS, INC.5660 NEW NORTHSIDE DRIVE, N.W., SUITE 1100ATLANTAGA303281258CLARIANT CORPORATIONLEWIS & HARRISON122 C ST NW STE 740WASHINGTONDC2000149403